BSE Live
Oct 31, 16:01Prev. Close
137.05
Open Price
136.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:59Prev. Close
136.95
Open Price
136.09
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
135.19 (1878)
| Profit & Loss account of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 71.77 | 75.55 | 238.78 | 137.25 | 252.96 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 71.77 | 75.55 | 238.78 | 137.25 | 252.96 | |
| Total Operating Revenues | 71.77 | 75.55 | 238.78 | 137.25 | 252.96 | |
| Other Income | 1.79 | 29.47 | 10.88 | 6.84 | 5.41 | |
| Total Revenue | 73.56 | 105.01 | 249.66 | 144.09 | 258.37 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 23.12 | 28.13 | 22.11 | 18.27 | 18.18 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 222.59 | 280.24 | 281.41 | 179.28 | 247.40 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Employee Benefit Expenses | 108.96 | 118.53 | 107.00 | 96.78 | 91.59 | |
| Finance Costs | 8.91 | 1.66 | 7.63 | 13.33 | 10.65 | |
| Depreciation And Amortisation Expenses | 10.83 | 12.13 | 11.77 | 10.16 | 10.92 | |
| Other Expenses | 44.37 | 52.44 | 42.31 | 29.67 | 30.77 | |
| Total Expenses | 418.78 | 493.12 | 472.24 | 347.49 | 409.51 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 | |
| Profit/Loss From Continuing Operations | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 | |
| Profit/Loss For The Period | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -10.64 | -11.96 | -7.82 | -7.73 | -5.77 | |
| Diluted EPS (Rs.) | -10.64 | -11.96 | -7.82 | 7.73 | -5.77 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
20.05.2025
Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
20.05.2025
Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
20.05.2025
Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
20.05.2025
Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y